5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy.
about
Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instabilityHydroquinone increases 5-hydroxymethylcytosine formation through ten eleven translocation 1 (TET1) 5-methylcytosine dioxygenaseMolecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer developmentRegulation of translocator protein 18 kDa (TSPO) expression in health and disease statesChemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sitesDown-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter regionEpigenetics in non-small cell lung cancer: from basics to therapeuticsPhysiological and pathological implications of 5-hydroxymethylcytosine in diseasesTowards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implicationsRASSF tumor suppressor gene family: biological functions and regulationE-cadherin and gastric cancer: cause, consequence, and applicationsMicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tuneNovel epigenetic target therapy for prostate cancer: a preclinical studyAzacitidine-induced cryptogenic organizing pneumonia: a case report and review of the literatureModeling Fragile X Syndrome Using Human Pluripotent Stem CellsAdvancements in the delivery of epigenetic drugsThe retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycleFlow-Dependent Epigenetic DNA Methylation in Endothelial Gene Expression and AtherosclerosisRegulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cellsAberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signalEffect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemiaAnalysis of DNA methylation and gene expression in radiation-resistant head and neck tumorsEpigenetic regulation of HIV-1 latency by cytosine methylationNewly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compoundsOxidative stress induces monocyte necrosis with enrichment of cell-bound albumin and overexpression of endoplasmic reticulum and mitochondrial chaperonesEstablishment of IL-7 Expression Reporter Human Cell Lines, and Their Feasibility for High-Throughput Screening of IL-7-Upregulating ChemicalsReactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulationRole of protein tyrosine phosphatases in cancerPostintegrative gene silencing within the Sleeping Beauty transposition systemMammalian PNLDC1 is a novel poly(A) specific exonuclease with discrete expression during early developmentA TDG/CBP/RARα ternary complex mediates the retinoic acid-dependent expression of DNA methylation-sensitive genesGenome-wide demethylation by 5-aza-2'-deoxycytidine alters the cell fate of stem/progenitor cells.Sequential treatment with cytarabine and decitabine has an increased anti-leukemia effect compared to cytarabine alone in xenograft models of childhood acute myeloid leukemia.Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP miceDifferential DNA methylation at conserved non-genic elements and evidence for transgenerational inheritance following developmental exposure to mono(2-ethylhexyl) phthalate and 5-azacytidine in zebrafishReciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma
P2860
Q21134904-908D4C32-A56F-4F31-8071-2F325307C537Q24292772-C51A783C-FB20-4112-9823-B1E1473AAF55Q24614496-9A05094F-B857-416D-A126-AA3F3BB66378Q24616554-3B4435AB-57BD-4DBE-B435-EE456888C770Q24631648-4AA2DAFB-B729-4392-A9D2-8E31C58554CAQ24806085-480F45BA-DA8B-4301-A4DF-25A7FA9F187DQ24810666-52A27D5D-126A-41C9-AD3F-C4A2253314D0Q26749113-A1AE7F50-9C65-4186-B950-0541C7A95AB7Q26749375-D7B29590-F766-4BB1-A07C-3D925A5DC3FEQ26783490-18A1FFB0-E8A5-4038-9974-7EFF0CEA15C3Q26866080-3183DEC0-27D8-482E-8450-17F5C24455ADQ27000278-5A0CF0D9-C2BA-468C-9493-3C2BCA36D0CDQ27013740-797E42C1-8177-4AA4-BA1C-7A1BDDE90A92Q27330048-46F6F0AF-4A2A-4813-A8F0-52D36A351214Q28078522-9DB77C47-8D75-44AC-9054-918CD8637C24Q28080022-0EBC069C-C2BF-4975-96B0-B3FCB6CFC92DQ28088478-7CCC0673-E333-4420-AEFE-BF71F40BDACFQ28260808-89926F83-037B-4577-BFDE-0FBC303026F9Q28261711-50E3A23E-995F-415C-A2FA-23625C1A250EQ28291291-A9BD4B6C-7567-42CF-961D-68FEC4E1C191Q28306566-34A70D37-6AF2-4F53-AD49-9FF2999438A2Q28384242-4C4D9838-6869-4FBF-80DD-3BE9FEFA48F1Q28387220-7755BDD8-168F-469C-9CAA-14580A57ED83Q28392236-07FFFE02-CE50-4D29-B2EF-E3C224B17F6FQ28475636-0D7A215C-45BB-47CB-9C08-0065E3907D61Q28477252-8BC95446-041B-4859-BECA-FD2DDA77FFD0Q28488971-7E9EB551-2D4F-43E3-BC69-E9FA9648E43FQ28553886-821B4027-372E-44C0-8F2B-E17DA5B8122BQ28740315-1DD2F368-C8CC-46CC-9E5D-ABED5189AB78Q28741003-5E826B0E-9816-47C2-8218-C13AB309CE3CQ28756070-2BFC6AD8-A3A8-475F-9EB5-4C3C5F6B2A54Q28854360-9BF85F54-7393-440D-9D13-D665F2E77619Q30357571-6E00F9E0-F822-4359-81BC-00F081CAD95AQ30392550-C27E96FC-AFE3-4CB8-961F-2B4D4E1D71A3Q31149399-1154514D-A21A-439E-93D1-1FDA73ECAA1AQ33300134-26945021-F0C4-4671-AF1F-6FE33CCF4F68Q33523039-CD3CED54-5FD3-4C05-B2A7-1987144AB7C1Q33556422-57C00562-5C75-4D45-A1C5-9D04EA45A1C7Q33599015-4BDDFDF0-FE72-402E-8692-6D44B1379348Q33677445-128ACE91-BDF9-401F-AAD2-C9B08F13D38D
P2860
5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@ast
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@en
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@nl
type
label
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@ast
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@en
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@nl
prefLabel
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@ast
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@en
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@nl
P356
P1433
P1476
5-Azacytidine and 5-aza-2'-deo ...... plications for cancer therapy.
@en
P2093
Judith K Christman
P2888
P304
P356
10.1038/SJ.ONC.1205699
P407
P577
2002-08-01T00:00:00Z
P5875
P6179
1015413259